Downstream regulatory element antagonistic modulator regulates islet prodynorphin expression

American Journal of Physiology - Endocrinology and Metabolism

Volumn 291, Issue 3, 2006, Pages

  Jacobson, David A ^a   Cho, Julie ^b   Landa Jr , Luis R ^a   Tamarina, Natalia A ^a   Roe, Michael W ^a   Buxbaum, Joseph D ^b   Philipson, Louis H ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Calsenilin; Dynorphin; Glucagon; Neuroendocrine; Potassium channel interacting protein

Indexed keywords

CALSENILIN; DYNORPHIN A; GLUCOSE; KAPPA OPIATE RECEPTOR; PRODYNORPHIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM BINDING; CALCIUM CELL LEVEL; CONTROLLED STUDY; GLUCAGON RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NEUROSECRETORY CELL; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; CALCIUM; CELL LINE; CELL NUCLEUS; DNA; DYNORPHINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENKEPHALINS; GENE EXPRESSION REGULATION; GLUCAGON; GLUCAGON-SECRETING CELLS; GLUCOSE; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; KV CHANNEL-INTERACTING PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NALTREXONE; PROTEIN BINDING; PROTEIN PRECURSORS; RECEPTORS, OPIOID, KAPPA; REPRESSOR PROTEINS;

EID: 33748450581     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00612.2005     Document Type: Article

References (55)

1. An WF, Bowlby MR, Betty M, Cao J, Ling HP, Mendoza G, Hinson JW, Mattsson KI, Strassle BW, Trimmer JS, and Rhodes KJ. Modulation of A-type potassium channels by a family of calcium sensors. Nature 403: 553-556, 2000.
2. Ashcroft FM, Proks P, Smith PA, Ammala C, Bokvist K, and Rorsman P. Stimulus-secretion coupling in pancreatic β-cells. J Cell Biochem 55: 54-65, 1994.
3. Bahring R, Dannenberg J, Peters HC, Leicher T, Pongs O, and Isbrandt D. Conserved Kv4 N-terminal domain critical for effects of Kv channel-interacting protein 2.2 on channel expression and gating. J Biol Chem 276: 23888-23894, 2001.
4. Berggren PO, Ostenson CG, Petersson B, and Hellman B. Evidence for divergent glucose effects on calcium metabolism in pancreatic beta- and alpha2-cells. Endocrinology 105: 1463-1468, 1979.
5. Bergsten P, Grapengiesser E, Gylfe E, Tengholm A, and Hellman B. Synchronous oscillations of cytoplasmic Ca2+ and insulin release in glucose-stimulated pancreatic islets. J Biol Chem 269: 8749-8753, 1994.
6. Braun M, Wendt A, Birnir B, Broman J, Eliasson L, Galvanovskis J, Gromada J, Mulder H, and Rorsman P. GABAB receptor activation inhibits exocytosis in rat pancreatic beta-cells by G-protein-dependent activation of calcineurin. J Gen Physiol 123: 191-204, 2004.
7. Buxbaum JD, Choi EK, Luo Y, Lilliehook C, Crowley AC, Merriam DE, and Wasco W. Calsenilin a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nat Med 10: 1177-1181, 1998.
8. Carrion AM, Mellstrom B, and Naranjo JR. Protein kinase A-dependent derepression of the human prodynorphin gene via differential binding to an intragenic silencer element. Mol Cell Biol 18: 6921-6929, 1998.
9. Carrion AM, Link WA, Ledo F, Mellstrom B, and Naranjo JR. DREAM is a Ca2+-regulated transcriptional repressor. Nature 398: 80-84, 1999.
10. Cheng HY, Pitcher GM, Laviolette SR, Whishaw IQ, Tong KI, Kockeritz LK, Wada T, Joza NA, Crackower M, Goncalves J, Sarosi I, Woodgett JR, Oliveira-dos-Santos AJ, Ikura M, van der Kooy D, Salter MW, and Penninger JM. DREAM is a critical transcriptional repressor for pain modulation. Cell 108: 31-43, 2002.
11. Choi EK, Zaidi NF, Miller JS, Crowley AC, Merriam DE, Lilliehook C, Buxbaum JD, and Wasco W. Calsenilin is a substrate for caspase-3 that preferentially interacts with the familial Alzheimer's disease-associated C-terminal fragment of presenilin 2. J Biol Chem 276: 19197-19204, 2001.
12. Choi EK, Miller JS, Zaidi NF, Salih E, Buxbaum JD, and Wasco W. Phosphorylation of calsenilin at Ser63 regulates its cleavage by caspase-3. Mol Cell Neurosci 23: 495-506, 2003.
13. Dignam JD, Lebovitz RM, and Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489, 1983.
14. El Daly ES. Effect of intrathecal morphine on blood glucose, glucagon and tissue glycogen in rat: comparison with the effect of xanthan gum on blood glucose. J Pharm Belg 51: 195-199, 1996.
15. Gastaldelli A, Baldi S, Pettiti M, Toschi E, Camastra S, Natali A, Landau BR, and Ferrannini E. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 49: 1367-1373, 2000.
16. Giugliano D. Morphine, opioid peptides, and pancreatic islet function. Diabetes Care 7: 92-98, 1984.
17. Gopel SO, Kanno T, Barg S, and Rorsman P. Patch-clamp characterisation of somatostatin-secreting cells in intact mouse pancreatic islets. J Physiol 528: 497-507, 2000.
18. Impey S, Mark M, Villacres EC, Poser S, Chavkin C, and Storm DR. Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus. Neuron 16: 973-982, 1996.
19. Ipp E, Schusdziarra V, Harris V, and Unger RH. Morphine-induced hyperglycemia: role of insulin and glucagon. Endocrinology 107: 461-463 1980.
20. Johansen O, Tonnesen T, Jensen T, Jorde R, Burhol PG, and Reikeras O. Morphine effects on the release of glucagon, insulin and somatostatin from the isolated, perfused rat pancreas. Life Sci 51: 1237-1242 1992.
21. Josefsen K, Buschard K, Sorensen LR, Wollike M, Ekman R, and Birkenbach M. Glucose stimulation of pancreatic beta-cell lines induces expression and secretion of dynorphin. Endocrinology 139: 4329-4336, 1998.
22. Kanter RA, Ensinck JW, and Fujimoto WY. Disparate effects of enkephalin and morphine upon insulin and glucagon secretion by islet cell cultures. Diabetes 29: 84-86 1980.
23. Khawaja XZ, Green IC, Thorpe JR, and Bailey CJ. Increased sensitivity to insulin-releasing and glucoregulatory effects of dynorphin A1-13 and U 50488h in ob/ob versus lean mice. Diabetes 39: 1289-1297 1990.
24. Khawaja XZ, Green IC, Thorpe JR, and Titheradge MA. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain. Biochem J 267: 233-40 1990.
25. Lacy PE and Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35-39, 1967.
26. Lawrence MC, Bhatt HS, and Easom RA. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1. Diabetes 51: 691-698, 2002.
27. Levallet J, Koskimies P, Rahman N, and Huhtaniemi I. The promoter of murine follicle-stimulating hormone receptor: functional characterization and regulation by transcription factor steroidogenic factor 1. Mol Endocrinol 15: 80-92, 2001.
28. Lilliehook C, Chan S, Choi EK, Zaidi NF, Wasco W, Mattson MP, and Buxbaum JD. Calsenilin enhances apoptosis by altering endoplasmic reticulum calcium signaling. Mol Cell Neurosci 4: 552-559, 2002.
29. Lilliehook C, Bozdagi O, Yao J, Gomez-Ramirez M, Zaidi NF, Wasco W, Gandy S, Santucci AC, Haroutunian V, Huntley GW, and Buxbaum JD. Altered Aβ-formation and long-term potentiation in a calsenilin knock-out. J Neurosci 23: 9097-9106, 2003.
30. Link WA, Ledo F, Torres B, Palczewska M, Madsen TM, Savignac M, Albar JP, Mellstrom B, and Naranjo JR. Day-night changes in downstream regulatory element antagonist modulator/potassium channel interacting protein activity contribute to circadian gene expression in pineal gland. J Neurosci 24: 5346-5355, 2004.
31. Liu YJ, Vieira E, and Gylfe E. A store-operated mechanism determines the activity of the electrically excitable glucagon-secreting pancreatic alpha-cell. Cell Calcium 35, 357-65 2004.
32. Ma GH, Miller RJ, Kuznetsov A, Philipson LH. kappa-Opioid receptor activates an inwardly rectifying K+ channel by a G protein-linked mechanism: coexpression in Xenopus oocytes. Mol Pharmacol 47: 1035-1040, 1995.
33. Malaisse WJ, Blachier F, Pochet R, Manuel y Keenoy B, and Sener A. Calmodulin and calbindin in pancreatic islet cells. Adv Exp Med Biol 269: 127-133, 1990.
34. Melloul D. Transcription factors in islet development and physiology: role of PDX-1 in beta-cell function. Ann NY Acad Sci 1014: 28-37, 2004.
35. Nagai T, Sawano A, Park ES, and Miyawaki A. Circularly permuted green fluorescent proteins engineered to sense Ca2+. Proc Natl Acad Sci USA 98: 3197-3202, 2001.
36. Ohsugi M, Cras-Meneur C, Zhou Y, Warren W, Bernal-Mizrachi E, and Permutt MA. Glucose and insulin treatment of insulinoma cells results in transcriptional regulation of a common set of genes. Diabetes 53: 1496-1508, 2004.
37. Ohya S and Horowitz B. Differential transcriptional expression of Ca2+ BP superfamilies in murine gastrointestinal smooth muscles. Am J Physiol Gastrointest Liver Physiol 283: G1290-G1297, 2002.
38. Osawa M, Tong KI, Lilliehook C, Wasco W, Buxbaum JD, Cheng HY, Penninger JM, Ikura M, and Ames JB. Calcium-regulated DNA binding and oligomerization of the neuronal calcium-sensing protein, calsenilin/DREAM/KChIP3. J Biol Chem 276: 41005-4101 2001.
39. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: 2002-2007, 2001.
40. Radosevich PM, Williams PE, Lacy DB, McRae JR, Steiner KE, Cherrington AD, Lacy WW, and Abumrad NN. Effects of morphine on glucose homeostasis in the conscious dog. J Clin Invest 74: 1473-1480 1984.
41. Roe MW, Lancaster ME, Mertz RJ, Worley JF III, and Dukes ID. Voltage-dependent intracellular calcium release from mouse islets stimulated by glucose. J Biol Chem 268: 9953-9956 1993.
42. Rorsman P, Ashcroft FM, and Berggren PO. Regulation of glucagon release from pancreatic A-cells. Biochem Pharmacol 41:1783-17905, 1991.
43. Rorsman P, Berggren PO, Bokvist K, Ericson H, Mohler H, Ostenson CG, and Smith PA. Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels. Nature 341: 233-236, 1998.
44. Schwaninger M, Lux G, Blume R, Oetjen E, Hidaka H, and Knepel W. Membrane depolarization and calcium influx induce glucagon gene transcription in pancreatic islet cells through the cyclic AMP-responsive element. J Biol Chem 268: 5168-5177, 1993.
45. Sheng JZ and Wong TM. Chronic U50,488H abolishes inositol 1,4,5-triphosphate and intracellular Ca2+ elevations evoked by -opioid receptor in rat myocytes. Eur J Pharmacol 307: 323-329, 1996.
46. Shibata R, Misonou H, Campomanes CR, Anderson AE, Schrader LA, Doliveira LC, Carroll KI, Sweatt JD, Rhodes KJ, and Trimmer JS. A fundamental role for KChIPs in determining the molecular properties and trafficking of Kv4.2 potassium channels. J Biol Chem 278: 36445-36454, 2003.
47. Suzuki T and Takimoto K. Differential expression of Kv4 pore-forming and KChIP auxiliary subunits in rat uterus during pregnancy. Am J Physiol Endocrinol Metab 288: E335-E341, 2005.
48. Tai KK, Bian CF, and Wong TM. Opioid receptor stimulation increase intracellular free calcium in isolated rat ventricular myocytes. Life Sci 51: 909-913, 1992.
49. Tamarina NA, Wang Y, Mariotto L, Kuznetsov A, Bond C, Adelman J, and Philipson LH. Small-conductance calcium-activated K+ channels are expressed in pancreatic islets and regulate glucose responses. Diabetes 52: 2000-2006, 2003.
50. Thomas D, Tovey SC, Collins TJ, Bootman MD, Berridge MJ, and Lipp P. A comparison of fluorescent Ca2+ indicator properties and their use in measuring elementary and global Ca2+ signals. Cell Calcium 28: 213-223, 2000.
51. Unger RH. Glucagon physiology and pathophysiology in the light of new advances. Diabetologia 28: 574-578, 1985.
52. Ventura C, Spurgeon H, Lakatta EG, Guarnieri C, and Capogrossi MC. Opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular poll in myocytes and neurons. Circ Res 70: 66-81, 1992.
53. 2+ pathway in the cardiac κ-opioid receptor. Am J Physiol Cell Physiol 274: C82-C87, 1998.
54. Zhang M, Zheng M, and Schleicher RL. Autoradiographic localization of beta-endorphin binding in the pancreas. Mol Cell Neurosci 5: 684-690 1994.
55. Zhou YP, Pena JC, Roe MW, Mittal A, Levisetti M, Baldwin AC, Pugh W, Ostrega D, Ahmed N, Bindokas VP, Philipson LH, Hanahan D, Thompson CB, and Polonsky KS. Overexpression of Bcl-x(L) in β-cells prevents cell death but impairs mitochondrial signal for insulin secretion. Am J Physiol Endocrinol Metab 278: E340-E351, 2000.